Clinical Trial Update: Optical Surface Monitoring Technology-Guided Large-Segment Radiotherapy for Breast Cancer [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluating optical surface monitoring technology-guided large-segment radiotherapy for breast cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Breast Cancer, Optical Surface Monitoring Technology | Phase 2, Phase 3 | Status: RECRUITING